rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-2-15
|
pubmed:abstractText |
Polymorphisms in the promoter of the interleukin-10 (IL-10) gene may influence tumor development by altering the levels of IL-10 present in the serum or tumor microenvironment. In this study we looked for evidence of specific polymorphisms of the IL-10 promoter and whether lymphocyte expression of IL-10 correlates with specific genotypes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-5347
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
173
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
709-12
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15711248-Adult,
pubmed-meshheading:15711248-Carcinoma, Renal Cell,
pubmed-meshheading:15711248-Female,
pubmed-meshheading:15711248-Genotype,
pubmed-meshheading:15711248-Humans,
pubmed-meshheading:15711248-Interleukin-10,
pubmed-meshheading:15711248-Kidney Neoplasms,
pubmed-meshheading:15711248-Polymorphism, Genetic,
pubmed-meshheading:15711248-Promoter Regions, Genetic
|
pubmed:year |
2005
|
pubmed:articleTitle |
An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma.
|
pubmed:affiliation |
Department of Urology, St.George's Hospital Medical School, London, United Kingdom.
|
pubmed:publicationType |
Journal Article
|